We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWE:NASDAQNorthWestern Energy Group, Inc. Analysis

Data as of 2026-04-21 - not real-time

$70.57

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

NorthWestern Energy is trading at $70.57, comfortably above its 20‑day ($69.02) and 50‑day ($68.74) moving averages and the 200‑day SMA ($62.73), indicating a bullish price bias. The MACD histogram is positive (0.32) and the signal line is bullish, while the RSI sits at a neutral 54, suggesting room for further upside but no immediate overbought condition. However, the discounted cash flow model places fair value near $41, implying the stock is significantly overvalued relative to intrinsic estimates, and the upside/downside metric points to a ~7% downside potential. The company boasts solid revenue growth (11% YoY) and healthy gross margins (57%), yet free cash flow is negative and debt-to-equity is high (119%), raising concerns about the sustainability of its 3.66% dividend, which carries an 89.8% payout ratio. Recent material news confirms shareholder approval of an all‑stock merger with Black Hills Energy, which could expand the customer base and improve scale but also adds integration and execution risk. Overall, the combination of technical strength, overvaluation, high leverage, and pending merger creates a mixed outlook.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price trading near resistance ($75.18) with limited upside
  • DCF fair value far below market price
  • High dividend payout ratio amid negative free cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • All‑stock merger with Black Hills Energy could boost scale
  • Revenue growth remains robust at 11% YoY
  • Debt load remains high, limiting financial flexibility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Regulated utility business provides stable cash flows
  • Attractive dividend yield but sustainability concerns
  • Integration risk from merger and continued leverage

Key Metrics & Analysis

Financial Health

Revenue Growth10.90%
Profit Margin11.24%
P/E Ratio24.0
ROE6.31%
ROA2.54%
Debt/Equity119.13
P/B Ratio1.5
Op. Cash Flow$394.5M
Free Cash Flow$-188033872
Industry P/E22.1

Technical Analysis

TrendBullish
RSI54.3
Support$64.19
Resistance$75.18
MA 20$69.02
MA 50$68.74
MA 200$62.73
MACDBullish
VolumeDecreasing
Fear & Greed Index86.63

Valuation

Fair Value$41.06
Target Price$65.70
Upside/Downside-6.90%
GradeOvervalued
TypeBlend
Dividend Yield3.66%

Risk Assessment

Beta0.24
Volatility29.25%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.